--- title: "Inflammatory Bowel Disease BOOM-IBD2 | Sutter Health" description: "BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of Inflammatory Bowel Disease (IBD)." url: "https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) / 4. Inflammatory Bowel Disease BOOM-IBD2 # Inflammatory Bowel Disease BOOM-IBD2 **Status:** Open to Enrollment [Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061#enroll) #### Study details View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06571669). #### Locations - Palo Alto #### Clinical trial FAQs Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs). The study is called ****BOOM-IBD2**** . It uses a small device that sends gentle electrical signals to a nerve that helps with bowel function. This therapy is called sacral neuromodulation, and it’s been used to treat fecal incontinence and overactive bladder for almost 30 years. Now, it’s being studied to see how it might also help people with UC by supporting the brain-gut connection and lowering inflammation.  Here are a few highlights: - It’s a ****non-drug therapy**** — a different approach that doesn’t involve more medication. - You can ****stay on your current UC treatment**** — no need to stop or switch your existing medications - The procedure is ****minimally invasive**** , takes less than an hour, and you can go home the same day. - The device is placed just under the skin, so ****nothing is visible outside the body**** . - Participation is completely voluntary and at ****no cost to you**** . ![Ryan A McConnell, M.D.](https://dyn.mktgcdn.com/p/LAIgIdYkiJk-DXnAW0o98yR3oSpGumxcc1pavHU7STQ/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100) Ryan A McConnell, M.D. Principal investigator [View profile](https://www.sutterhealth.org/research/investigators/ryan-a-mcconnell-md-1078064874) ## Email us to enroll - [Email Palo Alto](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Inflammatory%20Bowel%20Disease%20BOOM-IBD2%20in%20Palo%20Alto&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.) ## Related clinical trials [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) - Clinical trial ### [Ulcerative Colitis XmAb942-01](https://www.sutterhealth.org/research/clinical-trials/ulcerative-colitis-xmab942-01-2064309878) A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01 **Status:** Open to Enrollment - Clinical trial ### [Inflammatory Bowel Disease QUOTIENT](https://www.sutterhealth.org/research/clinical-trials/quotient-1049141942) Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission **Status:** Open to Enrollment - Clinical trial ### [Poseidon System for Fluid Management During Water-aided Colonoscopy](https://www.sutterhealth.org/research/clinical-trials/poseidon-system-for-fluid-management-during-water-aided-colonoscopy-2092097961) A Prospective, Pre-Market, Multicenter, Non-significant Risk Study to Validate the Performance of the Poseidon System for Fluid Management During Water-aided Colonoscopy **Status:** Open to Enrollment - Clinical trial ### [Stress Urinary Incontinence PAS001 ProACT](https://www.sutterhealth.org/research/clinical-trials/stress-urinary-incontinence-pas001-proact-2080051902) Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men **Status:** Open to Enrollment - Clinical trial ### [Chronic Nausea and Vomiting NAVIGATE](https://www.sutterhealth.org/research/clinical-trials/chronic-nausea-and-vomiting-navigate-2023207930) A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System **Status:** Open to Enrollment [View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Inflammatory Bowel Disease BOOM-IBD2"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061#medicalwebpage","name":"Inflammatory Bowel Disease BOOM-IBD2","description":"BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of Inflammatory Bowel Disease (IBD).","url":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061","inLanguage":"en-US","dateModified":"2026-05-21","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061#breadcrumblist"},"mentions":[{"@type":"Person","name":"Ryan A McConnell, M.D.","url":"https://www.sutterhealth.org/research/investigators/ryan-a-mcconnell-md-1078064874","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061#medicaltrial","name":"Inflammatory Bowel Disease BOOM-IBD2","alternateName":"BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of Inflammatory Bowel Disease (IBD).","url":"https://www.sutterhealth.org/research/clinical-trials/inflammatory-bowel-disease-boom-ibd2-2007479061","description":"The study is called BOOM-IBD2. It uses a small device that sends gentle electrical signals to a nerve that helps with bowel function. This therapy is called sacral neuromodulation, and it’s been used to treat fecal incontinence and overactive bladder for almost 30 years. Now, it’s being studied to see how it might also help people with UC by supporting the brain-gut connection and lowering inflammation. Here are a few highlights: It’s a non-drug therapy — a different approach that doesn’t involve more medication. You can stay on your current UC treatment — no need to stop or switch your existing medications The procedure is minimally invasive, takes less than an hour, and you can go home the same day. The device is placed just under the skin, so nothing is visible outside the body. Participation is completely voluntary and at no cost to you.","identifier":"NCT06571669","code":{"@type":"MedicalCode","codeValue":"NCT06571669","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT06571669","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Gastrointestinal Diseases"},{"@type":"MedicalCondition","name":"Ulcerative Colitis"},{"@type":"MedicalCondition","name":"Autoimmune Disease"}],"studyLocation":[{"@type":"AdministrativeArea","name":"Palo Alto"}]} ```